ABVC BIOPHARMA, INC.

ABVC

ABVC BIOPHARMA, INC.

ABVC

Insider Sentiment (TTM):

Last Purchase:2010-05-11Last Sale:2009-01-23Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:816,526Shares Outstanding:25,448,516Institutional Ownership Pct.:3.21%

Earnings Market Reaction:

Filing Date:2026-05-18Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Pharmaceutical Preparations

LLY JNJ ABBV MRK ABT PFE

ABVC BIOPHARMA, INC. (ABVC) — SEC Financial Statements & Analysis

ABVC BIOPHARMA, INC. (ABVC) files its annual 10-K and quarterly 10-Q reports directly with the SEC. The financial data below is sourced as-filed from EDGAR — balance sheet, income statement, and cash flow as reported, without normalization or third-party adjustments.

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Related Party	0	1	2	-	1	1	0	-0	0	0	1	-
Third Parties	1	-	-	-	-	-	-	-	-	-	-	-
Assets
Cash	-	-	-	-	-	-	-	-	-	-	1	-
Assets Current
Restricted Cash And Cash Equivalents At Carrying V…	-	-	-	-	-	-	-	-	-	-	-	1
Cash And Cash Equivalents At Carrying Value	0	1	0	0	0	0	0	0	0	0	-	0
Restricted Cash	-	-	-	-	-	-	-	-	1	1	1	-
Restricted Cash Current	-	1	20	20	1	1	1	1	-	20	-	-
Accounts Receivable Net Current	-	-	-	-	-	-	0	0	0	0	0	0
Inventory Net	-	-	0	0	0	-	-	-	-	-	-	-
Other Receivables Net Current	-	-	-	1	-	-	-	-	-	-	-	-
Short Term Investments	0	0	0	0	0	0	0	0	0	0	0	0
Prepaid Expense And Other Assets Current	0	0	0	0	0	0	0	0	0	0	0	0
Assets Current	1	3	3	3	1	2	2	2	2	2	2	2
Property Plant And Equipment Net	13	13	13	8	8	1	1	8	8	1	8	1
Operating Lease Right Of Use Asset	2	2	0	0	1	1	1	1	1	1	1	1
Long Term Investments	2	2	3	3	3	2	2	2	2	3	3	1
Deferred Income Tax Assets Net	-	-	-	-	-	-	-	-	-	-	0	0
Prepaid Expense Noncurrent	2	1	1	-	-	1	0	0	0	0	0	0
Security Deposit	-	-	-	-	-	-	0	0	0	0	0	0
Prepaid Expense And Other Assets Noncurrent	1	1	1	1	1	1	1	1	1	1	-	-
Other Assets Noncurrent	0	0	0	0	0	0	-	-	-	0	-	-
Assets	20	21	21	16	15	8	8	8	8	8	17	9
Short Term Bank Loans And Notes Payable	-	-	-	-	-	-	-	-	-	-	-	1
Liabilities
Liabilities And Stockhold…
Other Receivable After Allowance For Credit Loss N…	-	-	-	-	-	4	-	-	0	0	-	-
Liabilities Current
Short Term Borrowings	0	1	1	1	1	1	1	1	1	1	1	-
Accounts Payable And Other Accrued Liabilities Cur…	4	4	4	4	4	4	4	4	3	4	-	-
Accrued Liabilities Current	-	-	-	-	-	-	-	-	-	4	4	3
Customer Advances Current	-	-	-	-	-	-	-	-	-	-	-	0
Contract With Customer Liability Current	0	0	0	0	0	0	0	0	0	0	0	-
Operating Lease Liability Current	0	0	0	0	0	0	0	0	0	0	0	0
Other Liabilities Current	-	-	-	1	-	-	0	0	-	0	-	-
Convertible Notes Payable Current	-	-	-	0	-	-	-	1	1	1	-	-
Taxes Payable Current	0	0	0	0	-	-	-	-	0	0	-	-
Liabilities Current	5	6	7	7	7	7	6	6	6	6	5	6
Security Deposit Liability	-	-	0	0	0	0	0	0	0	0	0	0
Operating Lease Liability Noncurrent	2	2	0	0	0	0	0	0	0	0	1	1
Convertible Long Term Notes Payable	-	-	-	-	-	-	-	-	-	-	2	3
Liabilities	7	8	7	7	7	7	6	7	7	7	8	10
Equity
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	97	96	94	86	84	79	78	87	86	74	81	68
Stockholders Equity Note Subscriptions Receivable	-	-	-	-	-	-	-	-	-0	-0	-1	-1
Retained Earnings Accumulated Deficit	-78	-77	-74	-72	-70	-69	-71	-70	-69	-64	-62	-59
Accumulated Other Comprehensive Income Loss Define…	-	-	-	-	-	-	-	-	-	-	1	1
Accumulated Other Comprehensive Income Loss Net Of…	0	0	0	0	0	0	0	0	0	1	-	-
Treasury Stock Value	-9	-9	-9	-9	-9	-9	-9	-9	-9	-9	-9	-9
Stockholders Equity	11	13	12	9	5	1	2	2	1	1	9	-0
Minority Interest	2	2	2	2	3	-1	-0	-0	-0	-0	-0	0
Liabilities And Stockholders Equity	20	21	21	16	15	8	8	8	8	8	17	9
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Preferred Stock Shares Authorized	20	20	20	20	20	20	20	20	20	20	20	20
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	400	400	400	400	400	400	400	400	400	400	400	400
Common Stock Shares Issued	387	376	363	391	384	347	318	301	282	278	289	298
Shares Outstanding	26	25	24	20	15	14	13	12	11	4	5	3

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	11.21%	41.12%	-	-	-	-	-	-	-	-	-	-
2025	8.49%	73.58%	216.04%	-10.77%	1.01%	-5.72%	-8.45%	-17.91%	-30.41%	-29.58%	-24.65%	-19.72%
2024	-27.38%	-30.84%	-32.71%	-12.13%	-17.33%	-12.00%	-8.35%	19.06%	-6.17%	35.20%	72.07%	247.49%
2023	-	-	-	-41.18%	-56.68%	-37.43%	-4.80%	9.60%	20.00%	3.25%	-12.20%	-35.45%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 50+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	0.12	0.41	0.51	0.42	0.22	0.33	0.35	0.37	0.29	0.27	0.46	0.37
Quick Ratio	0.07	0.35	0.44	0.39	0.20	0.32	0.33	0.33	0.23	0.25	0.44	0.34
Working Capital	-4.74M	-3.66M	-3.23M	-3.76M	-5.26M	-4.38M	-4.08M	-3.94M	-4.38M	-4.45M	-2.87M	-3.64M
Leverage & Debt
Debt to Equity	0.64	0.58	0.56	0.71	1.28	9.41	3.92	4.22	4.47	5.21	0.83	-25.54
Interest Coverage TTM	-33.14	-17.20	-9.43	-5.06	-2.95	-3.54	-2.04	-1.98	-2.47	-2.71	-6.16	-25.32
Debt Ratio	0.35	0.37	0.32	0.42	0.47	0.90	0.83	0.81	0.82	0.84	0.45	1.04
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.06	0.04	0.05	0.07	0.03	0.00	-0.01	0.02	0.08	0.09
Days Sales Outstanding TTM	-	-	-	-	-	-	1.40	99.93	-267.70	119.55	8.59	51.37
Receivables Turnover TTM	-	-	-	-	-	-	260.71	3.65	-1.36	3.05	42.51	7.11
Per Share Metrics
Diluted EPS TTM	-0.34	-0.39	-0.27	-0.26	-0.21	-0.45	-0.41	-0.71	-0.96	-1.91	-2.98	-3.80
Free Cash Flow Per Share TTM	-0.13	-0.15	-0.13	-0.12	-0.09	-0.15	-0.12	-0.26	-0.38	-0.97	-1.05	-1.02
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	-	-	-	-	-	99.85%	8.58%	-1,452.88%	723.04%	-98.15%	29.83%	33.31%
Operating Profit Margin TTM	-25,270.54%	-22,503.10%	-618.20%	-785.80%	-409.25%	-923.34%	-1,131.65%	-25,095.89%	8,986.58%	-4,439.24%	-897.50%	-1,020.97%
Net Profit Margin TTM	-27,554.10%	-24,886.10%	-683.31%	-897.74%	-507.32%	-1,032.02%	-1,289.24%	-31,792.93%	10,954.61%	-5,432.56%	-1,157.24%	-1,171.57%
Growth Metrics
Net Revenue Growth (1Y)	-94.92%	-93.76%	129.48%	1,904.43%	-830.16%	234.31%	-61.88%	-97.63%	-106.21%	-84.28%	1,598.70%	806.45%
Net Income Growth (1Y)	175.93%	50.38%	21.63%	-43.40%	-66.19%	-36.49%	-57.53%	-35.82%	-22.82%	-49.58%	-35.01%	-24.92%
EPS Growth (1Y)	62.29%	-12.70%	-35.12%	-63.15%	-78.01%	-76.41%	-86.12%	-81.24%	-73.78%	-63.18%	-47.79%	-28.96%
Valuation Metrics
P/E TTM	-2.82	-5.42	-11.31	-8.48	-5.00	-1.31	-1.65	-1.09	-1.36	-0.61	-0.35	-1.37
P/B	2.29	3.22	5.86	4.08	2.94	9.51	5.16	5.69	8.75	4.01	0.47	-45.36
P/S TTM	776.77	1,347.81	77.26	76.09	25.36	13.52	21.25	345.49	-148.88	32.99	4.03	16.04
Market Cap	24.69M	42.83M	70.70M	38.69M	15.87M	6.89M	8.47M	8.76M	12.75M	5.03M	4.22M	17.21M
Enterprise Value	24.63M	42.26M	70.66M	38.73M	15.91M	6.86M	8.60M	9.82M	13.80M	5.78M	5.60M	19.76M
Calculated Values
Free Cash Flow TTM	-3.34M	-2.99M	-3.10M	-2.08M	-1.39M	-1.81M	-1.54M	-2.98M	-3.67M	-4.21M	-4.24M	-3.38M
Net Debt	-51.59K	-571.47K	-44.81K	49.82K	41.84K	-23.56K	126.38K	1.06M	1.04M	751.93K	1.39M	2.56M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2010-05-11Purchase

Owner: Nirta, Joseph

Title: -

Shares: 10,000

Price/Share: $0.15

Value: $1,500.00

Shares Owned: 10,000

Relationship: Director

Ownership: Indirect

2009-11-13Purchase

Owner: Smith, J.B.

Title: -

Shares: 714,286

Price/Share: $50000.00

Value: $35,714,300,000.00

Shares Owned: 16,585,538

Relationship: Director,TenPercentOwner

Ownership: Indirect

2009-08-31Purchase

Owner: Smith, J.B.

Title: -

Shares: 192,308

Price/Share: $50000.00

Value: $9,615,400,000.00

Shares Owned: 18,430,752

Relationship: Director,TenPercentOwner

Ownership: Indirect

2009-06-10Purchase

Owner: Smith, J.B.

Title: -

Shares: 20

Price/Share: $20000.00

Value: $400,000.00

Shares Owned: 336

Relationship: Director,TenPercentOwner

Ownership: Indirect

2009-06-02Purchase

Owner: Smith, J.B.

Title: -

Shares: 95

Price/Share: $47500.00

Value: $4,512,500.00

Shares Owned: 2,436

Relationship: Director,TenPercentOwner

Ownership: Indirect

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2010-05-11	Nirta, Joseph	Director	-	Indirect	Purchase	10,000	0.15	$1,500.00	10,000	4
2009-11-13	Smith, J.B.	Director,TenPercentOwner	-	Indirect	Purchase	714,286	50000.00	$35,714,300,000.00	16,585,538	4
2009-08-31	Smith, J.B.	Director,TenPercentOwner	-	Indirect	Purchase	192,308	50000.00	$9,615,400,000.00	18,430,752	4/A
2009-06-10	Smith, J.B.	Director,TenPercentOwner	-	Indirect	Purchase	20	20000.00	$400,000.00	336	4
2009-06-02	Smith, J.B.	Director,TenPercentOwner	-	Indirect	Purchase	95	47500.00	$4,512,500.00	2,436	4
2009-04-29	Smith, J.B.	Director,TenPercentOwner	-	Indirect	Purchase	34	34000.00	$1,156,000.00	2,381	4
2009-04-14	Smith, J.B.	Director,TenPercentOwner	-	Indirect	Purchase	21	21000.00	$441,000.00	2,347	4
2009-03-26	Smith, J.B.	Director,TenPercentOwner	-	Indirect	Purchase	80	80000.00	$6,400,000.00	2,326	4/A
2009-03-26	Ramsey, Sally Judith	Director,TenPercentOwner	-	Indirect	Purchase	80	80000.00	$6,400,000.00	2,326	4
2009-03-10	Smith, J.B.	Director,TenPercentOwner	-	Indirect	Purchase	23	23000.00	$529,000.00	2,246	4
2009-02-26	Smith, J.B.	Director,TenPercentOwner	-	Indirect	Purchase	40	40000.00	$1,600,000.00	2,223	4
2009-02-11	Smith, J.B.	Director,TenPercentOwner	-	Indirect	Purchase	30	30000.00	$900,000.00	2,158	4
2009-01-23	Stromback, Richard Dean	Director,TenPercentOwner	-	Direct	Sale	4,000,000	1.00	$4,000,000.00	10,637,500	4/A
2009-01-23	Stromback, Richard Dean	Director,TenPercentOwner	-	Direct	Sale	4,000,000	1.00	$4,000,000.00	10,637,500	4
2009-01-23	Smith, J.B.	Director,TenPercentOwner	-	Indirect	Purchase	4,000,000	-	-	5,500,000	4/A
2008-09-26	Smith, J.B.	Director	-	Indirect	Purchase	750	1000.00	$750,000.00	2,010	4
2007-07-30	Ramsey, Sally Judith	Officer	VP New Product Development	Direct	Purchase	3,000,000	0.00	$0.00	3,000,000	4/A
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

3.21%

Inst. Shares: 816,526

Shares Outstanding: 25,448,516

2025-12-31

4.26%

Inst. Shares: 856,228

Shares Outstanding: 20,108,944

2025-09-30

3.37%

Inst. Shares: 784,223

Shares Outstanding: 23,256,590

2025-06-30

4.23%

Inst. Shares: 734,754

Shares Outstanding: 17,386,536

2025-03-31

3.84%

Inst. Shares: 574,994

Shares Outstanding: 14,968,232

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	816,526	25,448,516	3.21%
2025-12-31	856,228	20,108,944	4.26%
2025-09-30	784,223	23,256,590	3.37%
2025-06-30	734,754	17,386,536	4.23%
2025-03-31	574,994	14,968,232	3.84%
2024-12-31	786,614	11,673,980	6.74%
2024-09-30	456,184	12,405,261	3.68%
2024-06-30	440,730	11,321,277	3.89%
2024-03-31	457,398	9,736,150	4.70%
2023-12-31	447,714	4,335,650	10.33%
2023-09-30	339,102	4,055,345	8.36%
2023-06-30	3,528,834	3,308,740	106.65%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

ABVC BIOPHARMA, INC. (ABVC) — SEC Financial Statements & Analysis

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.